Literature DB >> 17716786

CSF cortisol in Alzheimer's disease and mild cognitive impairment.

Julius Popp1, Karsten Schaper, Heike Kölsch, Gabriela Cvetanovska, Fatima Rommel, Dietrich Klingmüller, Richard Dodel, Ullrich Wüllner, Frank Jessen.   

Abstract

Hypercortisolaemia occurs in Alzheimer's disease (AD) and may be involved in the AD related neurodegenerative process. In order to determine whether brain structures are exposed to high cortisol concentrations early in AD, we measured cerebrospinal fluid (CSF) cortisol in 66 subjects with AD, 33 subjects with mild cognitive impairment (MCI) and 34 control subjects. CSF cortisol concentrations were higher in AD subjects compared to controls (p<0.001) and to MCI subjects (p=0.002). There was no significant increase of cortisol in MCI subjects compared with controls suggesting that the increase of CSF cortisol is not an early event in the course of AD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17716786     DOI: 10.1016/j.neurobiolaging.2007.07.007

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  18 in total

1.  Inverse association of cortisol serum levels with T-tau, P-tau 181 and P-tau 231 peptide levels and T-tau/Abeta 1-42 ratios in CSF in patients with mild Alzheimer's disease dementia.

Authors:  Christoph Laske; Elke Stransky; Andreas Fritsche; Gerhard W Eschweiler; Thomas Leyhe
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-09-19       Impact factor: 5.270

2.  Cerebrospinal fluid cortisol levels are higher in patients with delirium versus controls.

Authors:  Andrew Pearson; Annick de Vries; Scott D Middleton; Fiona Gillies; Timothy O White; Ian R Armstrong; Ruth Andrew; Jonathan R Seckl; Alasdair Mj MacLullich
Journal:  BMC Res Notes       Date:  2010-02-08

3.  Intranasal insulin increases regional cerebral blood flow in the insular cortex in men independently of cortisol manipulation.

Authors:  Thomas M Schilling; Diana S Ferreira de Sá; René Westerhausen; Florian Strelzyk; Mauro F Larra; Manfred Hallschmid; Egemen Savaskan; Melly S Oitzl; Hans-Peter Busch; Ewald Naumann; Hartmut Schächinger
Journal:  Hum Brain Mapp       Date:  2013-08-01       Impact factor: 5.038

4.  Associations between CSF cortisol and CSF norepinephrine in cognitively normal controls and patients with amnestic MCI and AD dementia.

Authors:  Lucy Y Wang; Murray A Raskind; Charles W Wilkinson; Jane B Shofer; Carl Sikkema; Patricia Szot; Joseph F Quinn; Douglas R Galasko; Elaine R Peskind
Journal:  Int J Geriatr Psychiatry       Date:  2018-02-15       Impact factor: 3.485

5.  Stress-induced anhedonia is associated with an increase in Alzheimer's disease-related markers.

Authors:  A Briones; S Gagno; E Martisova; M Dobarro; B Aisa; M Solas; R Tordera; Mj Ramírez
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

Review 6.  One is the deadliest number: the detrimental effects of social isolation on cerebrovascular diseases and cognition.

Authors:  Brett Friedler; Joshua Crapser; Louise McCullough
Journal:  Acta Neuropathol       Date:  2014-12-24       Impact factor: 17.088

7.  Intracerebroventricular Aβ-Induced Neuroinflammation Alters Peripheral Immune Responses in Rats.

Authors:  Pritha Gupta; Susmita Sil; Rupsa Ghosh; Arijit Ghosh; Tusharkanti Ghosh
Journal:  J Mol Neurosci       Date:  2018-10-31       Impact factor: 3.444

Review 8.  Early Life Stress and Epigenetics in Late-onset Alzheimer's Dementia: A Systematic Review.

Authors:  Erwin Lemche
Journal:  Curr Genomics       Date:  2018-11       Impact factor: 2.236

9.  Alzheimer's disease: a step closer to understanding type 3 diabetes in African Americans.

Authors:  Sherry A Ferguson; John J Panos; Daniel Sloper; Vijayalakshmi Varma; Sumit Sarkar
Journal:  Metab Brain Dis       Date:  2021-05-22       Impact factor: 3.584

10.  Metabolite profiling of Alzheimer's disease cerebrospinal fluid.

Authors:  Christian Czech; Peter Berndt; Kristina Busch; Oliver Schmitz; Jan Wiemer; Veronique Most; Harald Hampel; Jürgen Kastler; Hans Senn
Journal:  PLoS One       Date:  2012-02-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.